In vitro experiments showed that BumPeD triggers Survivin degradation via the ubiquitin‐proteasome pathway, inducing tumor apoptosis and suppressing bladder tumor cell proliferation and migration. The gene discussed is BIRC5; the disease is urinary bladder neoplasm.